PROJECTS1

Investing in the Future of Healthcare and FinTech

ABOUT ONCOLOGY ANALYTICS

Oncology Analytics, Inc. provides health plans, providers and patients with an evidence-based, technology-driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 3.5 million health plan members in the US and Puerto Rico, the Oncology Analytics e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy, and supportive care. The company’s real-world evidence analytics is based on tens of thousands of annual chemotherapeutic cases.

LEADERSHIP

CEO

Rick Dean, Chief Executive Officer

Oak HC/FT partner

Annie Lamont

Ezekiel J. Emanuel

Sector

Healthcare

Investment Stage

Early

Status

Private